Geode Capital Management’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Geode Capital Management’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-135,076	Closed	-$10.1M	–	4228
2015 Q3	$10.1M	Buy	135,076 +6,547	+5%	+$489K	0.01%	1329
2015 Q2	$9.68M	Buy	128,529 +10,385	+9%	+$556K	0.01%	1434
2015 Q1	$5.92M	Buy	118,144 +18,815	+19%	+$790K	﹤0.01%	1764
2014 Q4	$3.44M	Buy	99,329 +12,436	+14%	+$434K	﹤0.01%	2053
2014 Q3	$2.85M	Buy	86,893 +1,029	+1%	+$36.2K	﹤0.01%	2143
2014 Q2	$3.29M	Buy	85,864 +17,319	+25%	+$605K	﹤0.01%	2067
2014 Q1	$2.73M	Buy	68,545 +5,202	+8%	+$233K	﹤0.01%	2158
2013 Q4	$2.36M	Buy	63,343 +22,901	+57%	+$950K	﹤0.01%	2192
2013 Q3	$1.85M	Buy	40,442 +15,890	+65%	+$475K	﹤0.01%	2228
2013 Q2	$664K	Buy	+24,552	New	+$562K	﹤0.01%	2709

Geode Capital Management's KYTH Position: Q4 2015 in Review

Geode Capital Management sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 135,076 shares — an estimated $10.1M sold.

Geode Capital Management first reported a position in KYTH in Q2 2013 and held it in 10 quarters. The position peaked at $10.1M in Q3 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

Geode Capital Management reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
Geode Capital Management sold 135,076 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $10.1M.
Geode Capital Management first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2013 and held it in 10 quarters.
Geode Capital Management's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $10.1M in Q3 2015.
0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Geode Capital Management's 13F filing for Q4 2015, filed 12 Feb 2016.